Galmed Pharmaceuticals (EOCN) Share-based Compensation (2013 - 2026)
Galmed Pharmaceuticals (EOCN) recorded Share-based Compensation of $156,000 in Q2 2026, up 56.0% from $100,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Share-based Compensation (2013 - 2026) Analysis & Trends
On a TTM basis, Galmed Pharmaceuticals' Share-based Compensation came in at $137,000 as of Jun 30, 2026; for FY2025, it was $26,000, up 73.3% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of -58.3% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $15,000 in FY2024 (-98.3%), $892,000 in FY2023 (-31.2%), $1.3 million in FY2022 (-31.3%) and $1.89 million in FY2021 (-8.7%).
- Quarterly Share-based Compensation has ranged from -$400,000 in Q4 2024 to $574,000 in Q3 2021 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in two of the last six quarters, with an average decline of 1.4%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 56.0% in Q2 2026, against a decline of 63.2% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $156,000 (Q1 2026), -$280,000 (Q4 2025) and $105,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Galmed Pharmaceuticals | 422,361.40 | 422,361.40 | - | 156,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 156,000.00 |
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | -280,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 101,000.00 |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 195,000.00 |
| Sep 30, 2023 | 226,000.00 |
| Jun 30, 2023 | 174,000.00 |
| Mar 31, 2023 | 297,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 211,000.00 |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 457,000.00 |
| Dec 31, 2021 | 369,000.00 |
| Sep 30, 2021 | 574,000.00 |
API Access
Galmed Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();